Spacer
Spacer Home  |  Contact Us Spacer
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Spacer
Spacer
Developing Header

Alvine Pharmaceuticals, Inc., is a privately held, clinical stage company developing biologics to target autoimmune/inflammatory diseases.  Alvine’s lead product candidate, ALV003, is a mixture of two proteases engineered to degrade gluten. Gluten is the difficult to digest protein found in wheat, rye, and barley that triggers celiac disease in genetically susceptible individuals. Learn more about celiac disease. | learn more

Spacer Spacer To inquire about participating in the Phase 2b clinical study, email: info@alvinepharma.com
Gray Line

Beaker

Spacer Pipeline Header

ALV003 and other approaches to autoimmune/inflammatory diseases. | learn more

Spacer